Large Cap Biotechnology
Stocks Ranked by
Market Capitalization
Biotech and biopharmaceutical companies engaged in research, discovery, development, and production of innovative drug and drug- related technologies.
| Name | Market cap | Price |
Price change % |
|
|---|---|---|---|---|
1
Vertex Pharmaceuticals
VRTX
$99.8B
| $99.8B | $392.05 | 0.76% |
|
2
Regeneron Pharmaceuticals
REGN
$62.2B
| $62.2B | $579.61 | 1.25% |
|
3
Alnylam Pharmaceuticals
ALNY
$59.5B
| $59.5B | $452.33 | 0.41% |
|
4
argenx
ARGX
$43.3B
| $43.3B | $704.07 | 0.55% |
|
|
ONC
5
BeOne Medicines Ltd. American Depositary Shares
ONC
$35.7B
| $35.7B | $297.96 | 0.73% |
|
6
Insmed
INSM
$28.4B
| $28.4B | $134.97 | 0.33% |
|
7
BioNTech
BNTX
$24.8B
| $24.8B | $101.93 | 1.05% |
|
8
Summit Therapeutics
SMMT
$18.1B
| $18.1B | $24.42 | 1.57% |
|
9
Incyte
INCY
$16.6B
| $16.6B | $83.70 | 1.34% |
|
10
Royalty Pharma
RPRX
$15.6B
| $15.6B | $35.62 | 1.22% |
|
11
Genmab
GMAB
$15.4B
| $15.4B | $25.11 | 1.33% |
|
12
Ascendis Pharma
ASND
$11.7B
| $11.7B | $193.90 | 0.46% |
|
13
BioMarin Pharmaceuticals
BMRN
$11.3B
| $11.3B | $57.68 | 1.67% |
|
|
CAI
14
Caris Life Sciences, Inc. Common Stock
CAI
$10.8B
| $10.8B | $38.23 | 0.03% |
|
15
Exelixis
EXEL
$10.4B
| $10.4B | $37.90 | 1.58% |
|